Patrick C. Walsh

Active 1971–2025

241
Papers
61,495
Citations
135
h-index
240
i10-index

Citations

Citations per year for Patrick C. Walsh1952: 2 citations1971: 1 citations1972: 3 citations1973: 6 citations1974: 5 citations1975: 10 citations1976: 13 citations1977: 13 citations1978: 13 citations1979: 27 citations1980: 23 citations1981: 20 citations1982: 25 citations1983: 34 citations1984: 29 citations1985: 25 citations1986: 31 citations1987: 72 citations1988: 63 citations1989: 93 citations1990: 88 citations1991: 146 citations1992: 103 citations1993: 234 citations1994: 299 citations1995: 302 citations1996: 265 citations1997: 374 citations1998: 412 citations1999: 382 citations2000: 375 citations2001: 451 citations2002: 350 citations2003: 547 citations2004: 501 citations2005: 411 citations2006: 438 citations2007: 412 citations2008: 512 citations2009: 419 citations2010: 360 citations2011: 387 citations2012: 391 citations2013: 343 citations2014: 307 citations2015: 215 citations2016: 224 citations2017: 127 citations2018: 152 citations2019: 554 citations2020: 553 citations2021: 487 citations2022: 299 citations2023: 206 citations2024: 298 citations2025: 84 citations2026: 3 citations1953–1970: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,754 citing papers, 40.3% of this breakdownUnited Kingdom: 716 citing papers, 6.1% of this breakdownCanada: 624 citing papers, 5.3% of this breakdownGermany: 597 citing papers, 5.1% of this breakdownItaly: 507 citing papers, 4.3% of this breakdownChina: 402 citing papers, 3.4% of this breakdownNetherlands: 376 citing papers, 3.2% of this breakdownFrance: 374 citing papers, 3.2% of this breakdownAustralia: 347 citing papers, 2.9% of this breakdownSweden: 310 citing papers, 2.6% of this breakdownJapan: 272 citing papers, 2.3% of this breakdownBelgium: 179 citing papers, 1.5% of this breakdown
0%40.3%Other 19.8%

Fields

  • Medicine77.7%
  • Biochemistry, Genetics and Molecular Biology16.7%
  • Computer Science1.3%
  • Immunology and Microbiology0.5%
  • Engineering0.5%
  • Neuroscience0.5%
  • Other2.8%

Topics

  • Prostate Cancer Diagnosis and Treatment18.1%
  • Prostate Cancer Treatment and Research16.7%
  • Urinary Bladder and Prostate Research4.8%
  • Urologic and reproductive health conditions2.7%
  • Hormonal and reproductive studies2.7%
  • Advanced Radiotherapy Techniques2.1%
  • Other52.9%

Coauthors

All papers

Open in search
  1. Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

    Authors: , , , , , , - JAMA 2005 cited by 1,358

  2. The Development of Human Benign Prostatic Hyperplasia with Age

    Authors: , , , - The Journal of Urology 1984 cited by 2,506

  3. Germline Mutations in HOXB13 and Prostate-Cancer Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 670

  4. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael McGuire, Patrick C. Walsh, Brian T. Helfand, Charles B. Brendler, Qiang Ding, Jianfeng Xu, William B. Isaacs - European Urology 2016 cited by 341

  5. Prognostic G leason grade grouping: data based on the modified G leason scoring system

    Authors: , , , - British Journal of Urology 2013 cited by 629

  6. Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

    Authors: , , , , , , , , , , , , , , , - JAMA 1998 cited by 1,170

  7. Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy

    Authors: , , , , , , , , , , , , , , - The Journal of Urology 2011 cited by 642

  8. The natural history of metastatic progression in men with prostate‐specific antigen recurrence after radical prostatectomy: long‐term follow‐up

    Authors: , , , , , , , - British Journal of Urology 2011 cited by 274

  9. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maureen Sanderson, Dana C. Crawford, S. M. Gapstur, William S. Bush, Melinda C. Aldrich, Olivier Cussenot, György Petrovics, Jennifer Cullen, Christine Neslund‐Dudas, Rick A. Kittles, Jianfeng Xu, Mariana C. Stern, Anand P. Chokkalingam, Luc Multigner, Marie‐Élise Parent, F. Ménégaux, Géraldine Cancel‐Tassin, Adam S. Kibel, Eric A. Klein, Phyllis J. Goodman, Janet L. Stanford, Bettina F. Drake, Jennifer J. Hu, Peter E. Clark, Pascal Blanchet, Graham Casey, Anselm Hennis, Alexander Lubwama, Ian M. Thompson, Robin J. Leach, Susan Gundell, Loreall Pooler, James L. Mohler, Elizabeth T. H. Fontham, Gary J. Smith, Jack A. Taylor, Laurent Brureau, William J. Blot, Richard Biritwum, Evelyn Tay, Ann Truelove, Shelley Niwa, Yao Tettey, Rohit Varma, Roberta McKean‐Cowdin, Mina Torres, Mohamed Jalloh, Sérigne Maguèye Gueye, Lamine Niang, Olufemi J. Ogunbiyi, Michael O. Idowu, Olufemi Popoola, Akindele O. Adebiyi, Oseremen I. Aisuodionoe-Shadrach, Maxwell M. Nwegbu, Ben Adusei, Sunny Mante, Afua O.D. Abrahams, Edward D. Yeboah, James E. Mensah, Andrew A. Adjei, Halimatou Diop‐Ndiaye, Michael B. Cook, Stephen J. Chanock, Stephen Watya, Rosalind A. Eeles, Charleston W. K. Chiang, Joseph Lachance, Timothy R. Rebbeck, David V. Conti and 1 more - European Urology 2022 cited by 48

  10. Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2010 cited by 902

  11. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 1992 cited by 1,132

  12. Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

    Authors: , , , , , , , , , - Cancer Research 2004 cited by 529

  13. Impotence Following Radical Prostatectomy: Insight Into Etiology and Prevention

    Authors: , - The Journal of Urology 1982 cited by 1,469

  14. LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY

    Authors: , , , , - Urologic Clinics of North America 2001 cited by 1,031

  15. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Doug Easton, Zsofia Kote‐Jarai, Alice S. Whittemore, Chih-Lin Hsieh, Graham G. Giles, John L. Hopper, Gianluca Severi, William J. Catàlona, Diptasri Mandal, Elisa M. Ledet, William D. Foulkes, Nancy Hamel, Lovise Mahle, Pål Møller, Isaac J. Powell, Joan E. Bailey‐Wilson, John D. Carpten, Daniela Seminara, Kathleen A. Cooney, William B. Isaacs - Human Genetics 2012 cited by 198

  16. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin R. Loughlin, Grace L. Lu‐Yao, S. Bruce Malkowicz, Mark Mann, James Ryan Mark, Peter A. McCue, Martin Miner, Todd M. Morgan, Judd W. Moul, Ronald E. Myers, Sarah M. Nielsen, Elias Obeid, Christian P. Pavlovich, Stephen C. Peiper, David F. Penson, Daniel P. Petrylak, Curtis A. Pettaway, Robert Pilarski, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Mark E. Robson, Matt T. Rosenberg, Howard M. Sandler, Oliver Sartor, Edward M. Schaeffer, Gordon F. Schwartz, Mark S. Shahin, Neal D. Shore, Brian Shuch, Howard R. Soule, Scott A. Tomlins, Edouard J. Trabulsi, Robert G. Uzzo, Donald J. Vander Griend, Patrick C. Walsh, Carol J. Weil, Richard C. Wender, Leonard G. Gomella - Journal of Clinical Oncology 2017 cited by 193

  17. PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

    Authors: , , , , , , , , , , , , - Clinical Genitourinary Cancer 2019 cited by 46

  18. The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

    Authors: , , , , , , - The Journal of Urology 1993 cited by 1,308

  19. Death in Patients With Recurrent Prostate Cancer After Radical Prostatectomy: Prostate-Specific Antigen Doubling Time Subgroups and Their Associated Contributions to All-Cause Mortality

    Authors: , , , , , , - Journal of Clinical Oncology 2007 cited by 216

  20. Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - European Urology Oncology 2020 cited by 56

  21. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer Cullen, Christine Neslund‐Dudas, Rick A. Kittles, Jianfeng Xu, Mariana C. Stern, Zsofia Kote‐Jarai, Koveela Govindasami, Anand P. Chokkalingam, Luc Multigner, Marie‐Elise Parent, F. Ménégaux, Géraldine Cancel‐Tassin, Adam S. Kibel, Eric A. Klein, Phyllis J. Goodman, Bettina F. Drake, Jennifer J. Hu, Peter E. Clark, Pascal Blanchet, Graham Casey, Anselm Hennis, Alexander Lubwama, Ian M. Thompson, Robin J. Leach, Susan Gundell, Loreall Pooler, Lucy Xia, James L. Mohler, Elizabeth T. H. Fontham, Gary J. Smith, Jack A. Taylor, Rosalind A. Eeles, L. Brureau, Stephen J. Chanock, Stephen Watya, Janet L. Stanford, Diptasri Mandal, William B. Isaacs, Kathleen A. Cooney, William J. Blot, David V. Conti, Christopher A. Haiman - European Urology 2020 cited by 51

  22. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients

    Authors: , , , , , , , , , , - British Journal of Cancer 2021 cited by 29

  23. Family history and the risk of prostate cancer

    Authors: , , , , - The Prostate 1990 cited by 716

  24. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

    Authors: , , , , , - The Journal of Urology 2003 cited by 676